β-caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway

American Journal of Pathology

Volumn 178, Issue 3, 2011, Pages 1153-1166

  Bento, Allisson Freire ^a   Marcon, Rodrigo ^a   Dutra, Rafael Cypriano ^a   Claudino, Rafaela Franco ^a   Cola, Maíra ^a   Leite, Daniela Ferraz Pereira ^a   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; CANNABINOID 2 RECEPTOR; CARYOPHYLLENE; CASPASE 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXTRAN SULFATE; FORKHEAD TRANSCRIPTION FACTOR; GAMMA INTERFERON; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 4; KERATINOCYTE DERIVED CHEMOKINE; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY;

EID: 79952752154     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.052     Document Type: Article

References (76)

1. Cuzzocrea S: Emerging biotherapies for inflammatory bowel disease. Expert Opin Emerg Drugs 2003, 8:339-347
2. Podolsky DK: The current future understanding of inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2002, 16:933-943
3. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G: Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009, 15:100-113
4. Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, Freedman SB, Frigon NL, Games D, Hu K, Johnson-Wood K, Kappenman KE, Kawabe TT, Kola I, Kuehn R, Lee M, Liu W, Motter R, Nichols NF, Power M, Robertson DW, Schenk D, Schoor M, Shopp GM, Shuck ME, Sinha S, Svensson KA, Tatsuno G, Tintrup H, Wijsman J, Wright S, McConlogue L: BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 2001, 10:1317-1324 (Pubitemid 32600485)
5. D'Argenio G, Valenti M, Scaglione G, Cosenza V, Sorrentini I, Di Marzo V: Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB J 2006, 20:568-570 (Pubitemid 46671252)
6. Engel MA, Kellermann CA, Burnat G, Hahn EG, Rau T, Konturek PC: Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)- induced colitis. J Physiol Pharmacol 61:89-97
7. Galiègue S, Mary S, Marchand J, Dussossoy D, Carrière D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P: Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995, 232:54-61
8. Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN: Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med 2007, 13:492-497 (Pubitemid 46559830)
9. Bento AF, Leite DF, Claudino RF, Hara DB, Leal PC, Calixto JB: The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J Leukoc Biol 2008, 84:1213-1221
10. Kühl AA, Kakirman H, Janotta M, Dreher S, Cremer P, Pawlowski NN, Loddenkemper C, Heimesaat MM, Grollich K, Zeitz M, Farkas S, Hoffmann JC: Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 2007, 133:1882-1892 (Pubitemid 350180801)
11. Morgan NH, Stanford IM, Woodhall GL: Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology 2009, 57: 356-368
12. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA: Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310:329-332 (Pubitemid 41457202)
13. Liu J, Li H, Burstein SH, Zurier RB, Chen JD: Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid. Mol Pharmacol 2003, 63:983-992 (Pubitemid 36529916)
14. O'Sullivan SE, Tarling EJ, Bennett AJ, Kendall DA, Randall MD: Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma. Biochem Biophys Res Commun 2005, 337:824-831 (Pubitemid 41446988)
15. Rousseaux C, Lefebvre B, Dubuquoy L, Lefebvre P, Romano O, Auwerx J, Metzger D, Wahli W, Desvergne B, Naccari GC, Chavatte P, Farce A, Bulois P, Cortot A, Colombel JF, Desreumaux P: Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma. J Exp Med 2005, 201:1205-1215 (Pubitemid 40629065)
16. Schaefer KL, Denevich S, Ma C, Cooley SR, Nakajima A, Wada K, Schlezinger J, Sherr D, Saubermann LJ: Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor- gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms. Inflamm Bowel Dis 2005, 11: 244-252 (Pubitemid 40439678)
17. Jiang C, Ting AT, Seed B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86 (Pubitemid 28079219)
18. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82 (Pubitemid 28079218)
19. Wahli W: A gut feeling of the PXR, PPAR and NF-kappaB connection. J Intern Med 2008, 263:613-619
20. Dubuquoy L, Jansson EA, Deeb S, Rakotobe S, Karoui M, Colombel JF, Auwerx J, Pettersson S, Desreumaux P: Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003, 124:1265-1276 (Pubitemid 36531802)
21. Lefebvre M, Paulweber B, Fajas L, Woods J, McCrary C, Colombel JF, Najib J, Fruchart JC, Datz C, Vidal H, Desreumaux P, Auwerx J: Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. J Endocrinol 1999, 162:331-340 (Pubitemid 29447426)
22. Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N, Aubert JP: Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 2001, 49:544-551 (Pubitemid 32896986)
23. Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A: Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 2008, 105:9099-9104
24. Gertsch J: Anti-inflammatory cannabinoids in diet: towards a better understanding of CB(2) receptor action? Commun Integr Biol 2008, 1:26-28
25. Orav A, Stulova I, Kailas T, Müürisepp M: Effect of storage on the essential oil composition of Piper nigrum L. fruits of different ripening states. J Agric Food Chem 2004, 52:2582-2586
26. de Carvalho PM Jr, Rodrigues RF, Sawaya AC, Marques MO, Shimizu MT: Chemical composition and antimicrobial activity of the essential oil of Cordia verbenacea D.C. J Ethnopharmacol 2004, 95:297-301 (Pubitemid 39422686)
27. Ghia JE, Blennerhassett P, Collins SM: Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest 2008, 118:2209-2218 (Pubitemid 351872339)
28. Vandenbark AA, Chou YK, Whitham R, Mass M, Buenafe A, Liefeld D, Kavanagh D, Cooper S, Hashim GA, Offner H: Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial [Erratum appeared in Nat Med 1997;3:240]. Nat Med 1996, 2:1109-1115
29. Kimball ES, Wallace NH, Schneider CR, D'Andrea MR, Hornby PJ: Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice. Neurogastroenterol Motil 2004, 16:811-818 (Pubitemid 40022788)
30. Storr MA, Keenan CM, Zhang H, Patel KD, Makriyannis A, Sharkey KA: Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis. Inflamm Bowel Dis 2009, 15:1678-1685
31. Napimoga MH, Vieira SM, Dal-Secco D, Freitas A, Souto FO, Mestriner FL, Alves-Filho JC, Grespan R, Kawai T, Ferreira SH, Cunha FQ: Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy- Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway. J Immunol 2008, 180:609-617
32. Rogerio AP, Andrade EL, Leite DF, Figueiredo CP, Calixto JB: Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation. Br J Pharmacol 2009, 158:1074-1087
33. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254
34. Stanley ER: Murine bone marrow-derived macrophages. Methods Mol Biol 1997, 75:301-304
35. Vitor CE, Figueiredo CP, Hara DB, Bento AF, Mazzuco TL, Calixto JB: Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis. Br J Pharmacol 2009, 157:1034-1044
36. Baumgart DC, Carding SR: Inflammatory bowel disease: cause and immunobiology. Lancet 2007, 369:1627-1640 (Pubitemid 46722636)
37. Barker JN, Jones ML, Swenson CL, Sarma V, Mitra RS, Ward PA, Johnson KJ, Fantone JC, Dixit VM, Nickoloff BJ: Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-gamma. J Immunol 1991, 146:1192-1197
38. Arulampalam V, Pettersson S: Uncoupling the p38 MAPK kinase in IBD: a double edged sword? Gut 2002, 50:446-447
39. Harrington HA, Ho KL, Ghosh S, Tung KC: Construction and analysis of a modular model of caspase activation in apoptosis. Theor Biol Med Model 2008, 5:26
40. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984, 133:1710-1715 (Pubitemid 14035254)
41. Tsukita S, Furuse M: The structure and function of claudins, cell adhesion molecules at tight junctions. Ann N Y Acad Sci 2000, 915:129-135 (Pubitemid 32059373)
42. Klein TW: Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 2005, 5:400-411
43. Massa F, Marsicano G, Hermann H, Cannich A, Monory K, Cravatt BF, Ferri GL, Sibaev A, Storr M, Lutz B: The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 2004, 113:1202-1209 (Pubitemid 38544105)
44. Burstein S: PPAR-gamma: a nuclear receptor with affinity for cannabinoids. Life Sci 2005, 77:1674-1684
45. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD: A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999, 104:383-389 (Pubitemid 29534322)
46. Takagi T, Naito Y, Tomatsuri N, Handa O, Ichikawa H, Yoshida N, Yoshikawa T: Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade. Redox Rep 2002, 7:283-289 (Pubitemid 36032915)
47. Sánchez-Hidalgo M, Martín AR, Villegas I, de la Lastra CA.: Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats. Eur J Pharmacol 2007, 562:247-258 (Pubitemid 46560498)
48. Fernandes ES, Passos GF, Campos MM, Araújo JG, Pesquero JL, Avellar MC, Teixeira MM, Calixto JB: Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw. Br J Pharmacol 2003, 139:973-981 (Pubitemid 36877395)
49. Passos GF, Fernandes ES, Campos MM, Araújo JG, Pesquero JL, Souza GE, Avellar MC, Teixeira MM, Calixto JB: Kinin B1 receptor up-regulation after lipopolysaccharide administration: role of proinflammatory cytokines and neutrophil influx. J Immunol 2004, 172: 1839-1847 (Pubitemid 38116833)
50. Kanokmedhakul S, Kanokmedhakul K, Lekphrom R: Bioactive constituents of the roots of Polyalthia cerasoides. J Nat Prod 2007, 70:1536-1538 (Pubitemid 47584608)
51. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606 (Pubitemid 32531409)
52. Medeiros R, Passos GF, Vitor CE, Koepp J, Mazzuco TL, Pianowski LF, Campos MM, Calixto JB: Effect of two active compounds obtained from the essential oil of Cordia verbenacea on the acute inflammatory responses elicited by LPS in the rat paw. Br J Pharmacol 2007, 151:618-627 (Pubitemid 47016295)
53. Cho JY, Chang HJ, Lee SK, Kim HJ, Hwang JK, Chun HS: Amelioration of dextran sulfate sodium-induced colitis in mice by oral administration of beta-caryophyllene, a sesquiterpene. Life Sci 2007, 80: 932-939 (Pubitemid 46206052)
54. Ohkawara T, Nishihira J, Takeda H, Hige S, Kato M, Sugiyama T, Iwanaga T, Nakamura H, Mizue Y, Asaka M: Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 2002, 123:256-270 (Pubitemid 34747546)
55. Kanai T, Watanabe M, Okazawa A, Sato T, Yamazaki M, Okamoto S, Ishii H, Totsuka T, Iiyama R, Okamoto R, Ikeda M, Kurimoto M, Takeda K, Akira S, Hibi T: Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology 2001, 121:875-888 (Pubitemid 32959397)
56. Qualls JE, Kaplan AM, van Rooijen N, Cohen DA: Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol 2006, 80:802-815 (Pubitemid 44835899)
57. Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E: Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 2002, 47:1447-1457 (Pubitemid 34753919)
58. Oshima T, Miwa H, Joh T: Changes in the expression of claudins in active ulcerative colitis. J Gastroenterol Hepatol 2008, 23 Suppl 2:S146-S150
59. Granata F, Frattini A, Loffredo S, Del Prete A, Sozzani S, Marone G, Triggiani M: Signaling events involved in cytokine and chemokine production induced by secretory phospholipase A2 in human lung macrophages. Eur J Immunol 2006, 36:1938-1950 (Pubitemid 44089059)
60. Eckmann L, Nebelsiek T, Fingerle AA, Dann SM, Mages J, Lang R, Robine S, Kagnoff MF, Schmid RM, Karin M, Arkan MC, Greten FR: Opposing functions of IKKbeta during acute and chronic intestinal inflammation. Proc Natl Acad Sci USA 2008, 105:15058-15063
61. Cippitelli M, Sica A, Viggiano V, Ye J, Ghosh P, Birrer MJ, Young HA: Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. J Biol Chem 1995, 270:12548-12556
62. Samten B, Ghosh P, Yi AK, Weis SE, Lakey DL, Gonsky R, Pendurthi U, Wizel B, Zhang Y, Zhang M, Gong J, Fernandez M, Safi H, Vankayalapati R, Young HA, Barnes PF: Reduced expression of nuclear cyclic adenosine 5′-monophosphate response element-binding proteins and IFN-gamma promoter function in disease due to an intracellular pathogen. J Immunol 2002, 168:3520-3526 (Pubitemid 34250420)
63. Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW: Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000, 62: 240-248
64. Yano S, Ghosh P, Kusaba H, Buchholz M, Longo DL: Effect of promoter methylation on the regulation of IFN-gamma gene during in vitro differentiation of human peripheral blood T cells into a Th2 population. J Immunol 2003, 171:2510-2516 (Pubitemid 37025560)
65. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686 (Pubitemid 39457982)
66. Duchmann R, Zeitz M: T regulatory cell suppression of colitis: the role of TGF-beta. Gut 2006, 55:604-606
67. Correa F, Mestre L, Docagne F, Guaza C: Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling. Br J Pharmacol 2005, 145:441-448 (Pubitemid 40966273)
68. Saubermann LJ, Nakajima A, Wada K, Zhao S, Terauchi Y, Kadowaki T, Aburatani H, Matsuhashi N, Nagai R, Blumberg RS: Peroxisome proliferator- activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm Bowel Dis 2002, 8:330-339
69. Ramakers JD, Verstege MI, Thuijls G, Te Velde AA, Mensink RP, Plat J: The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis. J Clin Immunol 2007, 27:275-283 (Pubitemid 46790815)
70. Lu T, Newton C, Perkins I, Friedman H, Klein TW: Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection. J Pharmacol Exp Ther 2006, 319:269-276 (Pubitemid 44455132)
71. Tschöp J, Kasten KR, Nogueiras R, Goetzman HS, Cave CM, England LG, Dattilo J, Lentsch AB, Tschop MH, Caldwell CC: The cannabinoid receptor 2 is critical for the host response to sepsis. J Immunol 2009, 183:499-505
72. Tambe Y, Tsujiuchi H, Honda G, Ikeshiro Y, Tanaka S: Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene. Planta Med 1996, 62:469-470 (Pubitemid 26370345)
73. Konstantinopoulos PA, Vandoros GP, Sotiropoulou-Bonikou G, Kominea A, Papavassiliou AG: NF-kappaB/PPAR gamma and/or AP- 1/PPAR gamma 'on/off' switches and induction of CBP in colon adenocarcinomas: correlation with COX-2 expression. Int J Colorectal Dis 2007, 22:57-68
74. Herring AC, Kaminski NE: Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin- 2 secretion by activated thymocytes. J Pharmacol Exp Ther 1999, 291:1156-1163
75. Zhao CY, Wang YD, Zhou JY, Jia B, Cui JF: [An experimental study on the reverse mechanism of PPAR-gamma agonist rosiglitazone in rats with non-alcoholic steatohepatitis]. Chinese. Zhonghua Gan Zang Bing Za Zhi 2007, 15:450-455
76. O'Sullivan SE: Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 2007, 152:576-582